Effects of pre-treatment on odds of immune-related adverse events.

被引：0
|
作者：
Hunting, John
Olson, Eric
Faucheux, Andrew Thomas
Elko, Catherine A.
Knapp, Mary-Peyton
Price, Sarah
Brinton, Stephanie
Lycan, Thomas William, Jr.
机构：
[1] Wake Forest Baptist Med Ctr, Dept Internal Med, Winston Salem, NC USA
[2] Wake Forest Baptist Med Ctr, Dept Hematol & Oncol, Winston Salem, NC USA
[3] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC 27101 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2540
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Racial differences in development of immune-related adverse events.
    Bhandari, Shruti
    Kumar, Rohit
    Nice, Laura
    Cheema, Anmol
    Kloecker, Goetz H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab
    Mizutani, Kosuke
    Ito, Toshiki
    Takahara, Kiyoshi
    Ando, Ryosuke
    Ishihara, Takuma
    Yasui, Takahiro
    Shiroki, Ryoichi
    Miyake, Hideaki
    Koie, Takuya
    MEDICINE, 2021, 100 (13) : E25402
  • [3] Flu vaccination rate of patients with severe immune-related adverse events.
    Allen, Ian Matthew
    Murciano-Goroff, Yonina Robbie
    Zubiri, Leyre
    Li, Qun
    Hughes, Michael Sang
    Velimirovic, Marko
    Chu, Jacqueline N.
    Durbin, Sienna
    Klauer, Matthew J.
    Awadalla, Magid
    Petrillo, Laura A.
    Dougan, Michael
    Letourneau, Alyssa R.
    Mansour, Michael
    Neilan, Tomas G.
    Cohen, Justine Vanessa
    Bardia, Aditya
    Reynolds, Kerry Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Hospital admissions and subsequent outcomes from immune-related adverse events.
    Ho, Hui Jan
    Arneil, Melissa
    Xu, Wen
    Atkinson, Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] A composite T cell biomarker in pre-treatment blood samples correlates with detection of immune-related adverse events
    Goswami, Sangeeta
    Siddiqui, Bilal A.
    Subudhi, Sumit K.
    Basu, Sreyashi
    Yadav, Shalini S.
    Diab, Adi
    Sharma, Padmanee
    CANCER CELL, 2022, 40 (03) : 249 - 251
  • [6] Underlying host immune dysregulation in cancer patients developing immune-related adverse events.
    Gerber, David E.
    Khan, Shaheen
    Luo, Xin
    Khan, Saad A.
    Fattah, Farjana
    Saltarski, Jessica
    Gloria-McCutchen, Yvonne
    Park, Jason
    Xie, Yang
    Li, Quan
    Wakeland, Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses
    Blum, Steven M.
    Rouhani, Sherin J.
    Sullivan, Ryan J.
    IMMUNOLOGICAL REVIEWS, 2023, 318 (01) : 167 - 178
  • [8] Relationship between insurance status and diagnosis of cutaneous immune-related adverse events.
    Chang, Michael
    Krasnow, Nira A.
    Blum, Amy E.
    Pahalyants, Vartan
    Murphy, William S.
    Yoon, Jaewon
    Reynolds, Kerry Lynn
    Thompson, Leah L.
    Chen, Steven T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Efficacy of nivolumab in patients treated by corticosteroid due to immune-related adverse events.
    Higashiyama, Ryoko Inaba
    Horinouchi, Hidehito
    Sekine, Katsutoshi
    Matsumoto, Yuji
    Murakami, Shuji
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Ohe, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [10] Treatment Outcomes of Immune-Related Cutaneous Adverse Events
    Phillips, Gregory S.
    Wu, Jennifer
    Hellmann, Matthew D.
    Postow, Michael A.
    Rizvi, Naiyer A.
    Freites-Martinez, Azael
    Chan, Donald
    Dusza, Stephen
    Motzer, Robert J.
    Rosenberg, Jonathan E.
    Callahan, Margaret K.
    Chapman, Paul B.
    Geskin, Larisa
    Lopez, Adriana T.
    Reed, Vanessa A.
    Fabbrocini, Gabriella
    Annunziata, Maria Carmela
    Kukoyi, Oluwaseun
    Pabani, Aliyah
    Yang, Chih-Hsun
    Chung, Wen-Hung
    Markova, Alina
    Lacouture, Mario E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (30) : 2746 - +
12345